Genentech/Xoma Raptiva Clears FDA, Priced At 25% Discount to Amevive

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet